Your browser doesn't support javascript.
loading
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer.
Thomas, Parijatham S; Patel, Anisha B; Lee, J Jack; Liu, Diane D; Hernandez, Mike; Muzzio, Miguel; Contreras, Alejandro; Sepeda, Valerie; Mays, Carrie; Weber, Diane; Vornik, Lana A; Khan, Seema A; Dimond, Eileen; Heckman-Stoddard, Brandy M; Perloff, Marjorie; Brown, Powel H.
Afiliação
  • Thomas PS; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel AB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lee JJ; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Liu DD; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hernandez M; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Muzzio M; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Contreras A; IIT Research Institute, Chicago, Illinois.
  • Sepeda V; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mays C; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Weber D; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Vornik LA; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Khan SA; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dimond E; Department of Surgery, Northwestern University, Chicago, Illinois.
  • Heckman-Stoddard BM; National Cancer Institute, NIH, Bethesda, Maryland.
  • Perloff M; National Cancer Institute, NIH, Bethesda, Maryland.
  • Brown PH; National Cancer Institute, NIH, Bethesda, Maryland.
Cancer Prev Res (Phila) ; 16(1): 47-55, 2023 01 04.
Article em En | MEDLINE | ID: mdl-36228112
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bexaroteno / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bexaroteno / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article